ADCYAP1 and Stroke: One of the strengths of PACAP is probably its ability to reduce both neuronal cell death in the acute phase of stroke, to sustainably skew the inflammatory response toward a protective phenotype and to promote during the chronic phase of stroke the release of neurotrophic factors responsible for subsequent neuronal plasticity.